Insider · CIK 0001381980

Kjellson Nina S

Reports to the SEC for 13 companies · ARLINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001381980

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-08	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.6K sh	—	—	13,587
2025-02-05	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−3,511 sh	$13.76	−$48.3K	443,885
2025-02-05	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−1,890 sh	$13.76	−$26K	3,700,705
2025-01-23	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−4,825 sh	$16.26	−$78.5K	3,702,595
2025-01-21	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−3,993 sh	$16.36	−$65.3K	3,707,420
2025-01-17	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−12.8K sh	$16.40	−$210K	3,711,413
2025-01-17	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−461 sh	$16.40	−$7,560.446	447,396
2025-01-16	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−835 sh	$16.29	−$13.6K	447,857
2025-01-16	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−6,944 sh	$16.29	−$113K	3,724,221
2024-11-25	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−566 sh	$16.84	−$9,530.648	448,692
2024-11-25	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−4,706 sh	$16.84	−$79.2K	3,731,165
2024-11-07	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−2,371 sh	$17.32	−$41.1K	449,258
2024-11-07	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−19.7K sh	$17.32	−$342K	3,735,871
2024-11-06	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−46.9K sh	$17.18	−$805K	3,755,591
2024-11-06	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−5,635 sh	$17.18	−$96.8K	451,629
2024-11-05	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−1,126 sh	$16.77	−$18.9K	457,264
2024-11-05	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−9,367 sh	$16.77	−$157K	3,802,447
2024-11-04	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−960 sh	$17.01	−$16.3K	3,811,814
2024-11-04	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−116 sh	$17.01	−$1,972.696	458,390
2024-11-01	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−23.9K sh	$16.54	−$396K	3,813,378
2024-11-01	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−73 sh	$17.16	−$1,252.636	458,506
2024-11-01	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−2,878 sh	$16.54	−$47.6K	458,579
2024-11-01	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−604 sh	$17.16	−$10.4K	3,812,774
2024-10-31	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−89.4K sh	$16.46	−$1.47M	3,837,316
2024-10-31	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−10.8K sh	$16.46	−$177K	461,457
2024-10-30	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−1,189 sh	$16.17	−$19.2K	472,207
2024-10-30	TYRATyra Biosciences, Inc.S Sale	Director	SSale	−9,889 sh	$16.17	−$160K	3,926,706
2024-05-29	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.6K sh	—	—	18,600
2023-05-31	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,500
2022-06-13	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,500
2021-09-17	TYRATyra Biosciences, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−1.33M sh	—	—	0
2021-09-17	TYRATyra Biosciences, Inc.C Conversion	Director	CConversion	+473K sh	—	—	473,396
2021-09-17	TYRATyra Biosciences, Inc.C Conversion	Director	CConversion	+3.94M sh	—	—	3,963,595
2021-09-17	TYRATyra Biosciences, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−182K sh	—	—	0
2021-09-17	TYRATyra Biosciences, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−182K sh	—	—	0
2021-09-17	TYRATyra Biosciences, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−1.33M sh	—	—	0
2021-09-17	TYRATyra Biosciences, Inc.C Conversion	Director	CConversion	+473K sh	—	—	473,396
2021-09-17	TYRATyra Biosciences, Inc.C Conversion	Director	CConversion	+3.94M sh	—	—	3,936,595
2021-09-17	TYRATyra Biosciences, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−182K sh	—	—	0
2021-09-17	TYRATyra Biosciences, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−182K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	$1.52	−$19K	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2017-06-20	Ocera Therapeutics, Inc.A Award	Director	AAward	+12.5K sh	—	—	12,500
2017-04-12	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-06-14	Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2016-03-28	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2016-03-28	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Jun 104
Kjellson Nina S0001193125-26-266276
SEC(opens sec.gov)
Feb 74
Kjellson Nina S0000950170-25-016385
SEC(opens sec.gov)
Jan 274
Kjellson Nina S0000950170-25-009278
SEC(opens sec.gov)
Jan 214
Kjellson Nina S0000950170-25-007426
SEC(opens sec.gov)
Nov 264
Kjellson Nina S0000950170-24-131084
SEC(opens sec.gov)
Nov 84
Kjellson Nina S0000950170-24-124184
SEC(opens sec.gov)
Nov 64
Kjellson Nina S0000950170-24-122639
SEC(opens sec.gov)
Nov 14
Kjellson Nina S0000950170-24-120198
SEC(opens sec.gov)

Companies

Address

C/O ELOXX PHARMACEUTICALS, INC. P.O. BOX 274

ARLINGTON, MA, 02476